FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968816674> ?p ?o ?g. }

• W2968816674 abstract "Pancreatic cancer is a highly lethal malignancy with poor prognosis. Anillin (ANLN), an actin binding protein, is upregulated and plays an important role in many malignant tumors. However, the precise role of ANLN in pancreatic cancer remains unclear.The expression of ANLN and its association with pancreatic cancer patient survival were analyzed using an online database and confirmed by immunohistochemistry. The ANLN protein expression in pancreatic cancer cell lines was detected by Western blot. Cell proliferation, colony formation and transwell assays in vitro and in vivo tumor growth were used to determine the role of ANLN in pancreatic cancer. Gene expression microarray analysis and a series of in vitro assays were used to elucidate the mechanisms of ANLN regulating pancreatic cancer progression.We found that the ANLN expression was significantly upregulated in pancreatic cancer tissues and cell lines. The high expression of ANLN was associated with tumor size, tumor differentiation, TNM stage, lymph node metastasis, distant metastasis and poor prognosis in pancreatic cancer. ANLN downregulation significantly inhibited cell proliferation, colony formation, migration, invasion and tumorigenicity in nude mice. Meanwhile, we found that ANLN knockdown inhibited several cell-cell adhesion related genes, including the gene encoding LIM and SH3 protein 1 (LASP1). LASP1 upregulation partially reversed the tumor-suppressive effect of ANLN downregulation on pancreatic cancer cell progression. Moreover, we found that ANLN downregulation induced the expression of miR-218-5p which inhibited LASP1 expression through binding to its 3'UTR. We also found that ANLN-induced enhancer of zeste homolog 2 (EZH2) upregulation was involved in regulating miR-218-5p/LASP1 signaling axis. EZH2 upregulation or miR-218-5p downregulation partially reversed the tumor-suppressive effect of ANLN downregulation on pancreatic cancer cell progression.ANLN contributed to pancreatic cancer progression by regulating EZH2/miR-218-5p/LASP1 signaling axis. These findings suggest that ANLN may be a candidate therapeutic target in pancreatic cancer." @default.
• W2968816674 created "2019-08-22" @default.
• W2968816674 creator A5003272234 @default.
• W2968816674 creator A5006978008 @default.
• W2968816674 creator A5025615610 @default.
• W2968816674 creator A5027841986 @default.
• W2968816674 creator A5036035882 @default.
• W2968816674 creator A5053906364 @default.
• W2968816674 creator A5069709196 @default.
• W2968816674 creator A5071037763 @default.
• W2968816674 creator A5085873303 @default.
• W2968816674 date "2019-08-08" @default.
• W2968816674 modified "2023-10-18" @default.
• W2968816674 title "ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis" @default.
• W2968816674 cites W1827894590 @default.
• W2968816674 cites W1947921367 @default.
• W2968816674 cites W1990376682 @default.
• W2968816674 cites W1994406452 @default.
• W2968816674 cites W1998912314 @default.
• W2968816674 cites W2003808152 @default.
• W2968816674 cites W2013676093 @default.
• W2968816674 cites W2019223707 @default.
• W2968816674 cites W2019808498 @default.
• W2968816674 cites W2022993352 @default.
• W2968816674 cites W2027944956 @default.
• W2968816674 cites W2029023103 @default.
• W2968816674 cites W2053131431 @default.
• W2968816674 cites W2074157228 @default.
• W2968816674 cites W2078135973 @default.
• W2968816674 cites W2078816010 @default.
• W2968816674 cites W2084129691 @default.
• W2968816674 cites W2104327265 @default.
• W2968816674 cites W2105406852 @default.
• W2968816674 cites W2109227959 @default.
• W2968816674 cites W2114843025 @default.
• W2968816674 cites W2123964155 @default.
• W2968816674 cites W2130634531 @default.
• W2968816674 cites W2137103099 @default.
• W2968816674 cites W2144582774 @default.
• W2968816674 cites W2149441684 @default.
• W2968816674 cites W2151320045 @default.
• W2968816674 cites W2164503478 @default.
• W2968816674 cites W2301400563 @default.
• W2968816674 cites W2404620725 @default.
• W2968816674 cites W2415413944 @default.
• W2968816674 cites W2512937619 @default.
• W2968816674 cites W2527600617 @default.
• W2968816674 cites W2567074234 @default.
• W2968816674 cites W2595991151 @default.
• W2968816674 cites W2606553662 @default.
• W2968816674 cites W2607048340 @default.
• W2968816674 cites W2620413878 @default.
• W2968816674 cites W2623210147 @default.
• W2968816674 cites W2658062003 @default.
• W2968816674 cites W2726891392 @default.
• W2968816674 cites W2748736604 @default.
• W2968816674 cites W2769558006 @default.
• W2968816674 cites W2774648971 @default.
• W2968816674 cites W2785646213 @default.
• W2968816674 cites W2790559294 @default.
• W2968816674 cites W2796397026 @default.
• W2968816674 cites W2804737749 @default.
• W2968816674 cites W2805785080 @default.
• W2968816674 cites W2826737886 @default.
• W2968816674 cites W2887309038 @default.
• W2968816674 cites W2896027469 @default.
• W2968816674 cites W2902311188 @default.
• W2968816674 cites W2906635219 @default.
• W2968816674 cites W2924962230 @default.
• W2968816674 cites W319446539 @default.
• W2968816674 doi "https://doi.org/10.1186/s13046-019-1340-7" @default.
• W2968816674 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6686567" @default.
• W2968816674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31395079" @default.
• W2968816674 hasPublicationYear "2019" @default.
• W2968816674 type Work @default.
• W2968816674 sameAs 2968816674 @default.
• W2968816674 citedByCount "60" @default.
• W2968816674 countsByYear W29688166742019 @default.
• W2968816674 countsByYear W29688166742020 @default.
• W2968816674 countsByYear W29688166742021 @default.
• W2968816674 countsByYear W29688166742022 @default.
• W2968816674 countsByYear W29688166742023 @default.
• W2968816674 crossrefType "journal-article" @default.
• W2968816674 hasAuthorship W2968816674A5003272234 @default.
• W2968816674 hasAuthorship W2968816674A5006978008 @default.
• W2968816674 hasAuthorship W2968816674A5025615610 @default.
• W2968816674 hasAuthorship W2968816674A5027841986 @default.
• W2968816674 hasAuthorship W2968816674A5036035882 @default.
• W2968816674 hasAuthorship W2968816674A5053906364 @default.
• W2968816674 hasAuthorship W2968816674A5069709196 @default.
• W2968816674 hasAuthorship W2968816674A5071037763 @default.
• W2968816674 hasAuthorship W2968816674A5085873303 @default.
• W2968816674 hasBestOaLocation W29688166741 @default.
• W2968816674 hasConcept C104317684 @default.
• W2968816674 hasConcept C121608353 @default.
• W2968816674 hasConcept C127561419 @default.
• W2968816674 hasConcept C173396325 @default.
• W2968816674 hasConcept C2779013556 @default.
• W2968816674 hasConcept C2780210213 @default.
• W2968816674 hasConcept C2781018059 @default.

• next